[144] Kymera Therapeutics, Inc. SEC Filing

Rhea-AI Filing Summary

KYMR affiliate reported multiple sales of Common Stock under a Rule 10b5-1 plan and an exercise-based sale. The filing lists 10b5-1 dispositions on 03/25/2026 (24,727 shares, $1,984,554.44), 03/23/2026 (91,250 shares, $7,063,733.26), 03/11/2026 (25,758 shares, $2,145,673.70), and earlier March trades. The filing also shows an exercise of stock options for 7,600 shares on 03/31/2026 with cash consideration.

Insights

Insider Transactions Analyst

Multiple Rule 10b5-1 sales and an option exercise were reported by an affiliate, indicating planned dispositions rather than ad hoc trades.

All listed dispositions are described as 10b5-1 Sales on specific dates in March 2026, with per-trade share counts and gross proceeds provided. The filing notes an exercise of options to acquire 7,600 shares with cash on 03/31/2026.

These entries are routine disclosures of affiliate activity; cash-flow treatment for prior sales is shown as gross proceeds per trade. Timing and sequencing align with scheduled plan sales rather than discretionary open-market purchases.

Key Figures

10b5-1 sale: 24,727 shares Proceeds: $1,984,554.44 10b5-1 sale: 91,250 shares +4 more

7 metrics

10b5-1 sale 24,727 shares trade dated 03/25/2026

Proceeds $1,984,554.44 gross proceeds from 03/25/2026 trade

10b5-1 sale 91,250 shares trade dated 03/23/2026

Proceeds $7,063,733.26 gross proceeds from 03/23/2026 trade

10b5-1 sale 25,758 shares trade dated 03/11/2026

Proceeds $2,145,673.70 gross proceeds from 03/11/2026 trade

Option exercise 7,600 shares exercise of stock options on 03/31/2026, cash

Key Terms

10b5-1 Sales, Exercise of Stock Options, Form 144

3 terms

10b5-1 Sales regulatory

"10b5-1 Sales for JEREMY CHADWICK 500 North Beacon Street"

Exercise of Stock Options financial

"Securities To Be Sold ... Exercise of Stock Options ... 7,600"

Form 144 regulatory

"Filer Information ... 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	7600	604048.00	81642394	03/31/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/31/2026	Exercise of Stock Options	Issuer			7600	03/31/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for JEREMY CHADWICK 500 North Beacon Street, 4th Floor Watertown MA 02472	Common	03/25/2026	24727	1984554.44
10b5-1 Sales for JEREMY CHADWICK 500 North Beacon Street, 4th Floor Watertown MA 02472	Common	03/23/2026	91250	7063733.26
10b5-1 Sales for JEREMY CHADWICK 500 North Beacon Street, 4th Floor Watertown MA 02472	Common	03/11/2026	25758	2145673.70
JEREMY CHADWICK 500 North Beacon Street, 4th Floor Watertown MA 02472	Common	03/04/2026	3919	334272.49
JEREMY CHADWICK 500 North Beacon Street, 4th Floor Watertown MA 02472	Common	03/02/2026	2039	181321.64

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)